High-Efficacy Therapy Reduces Relapse Frequency in Active Secondary Progressive MS
Research published online in Neurology found that high-efficacy therapy is more effective than less potent drugs in reducing the number of relapses in secondary progressive multiple sclerosis (MS). But the study found no difference in the speed of disease progression between high- and low-efficacy therapy. Patients with MS are typically diagnosed with relapsing-remitting MS and…
